Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T9627 |
PHD-1-IN-1
|
HIF/HIF Prolyl-Hydroxylase | Chromatin/Epigenetic; Metabolism |
PHD-1-IN-1 是口服有效的缺氧诱导因子脯氨酰羟化酶结构域 1抑制剂,IC50为 0.034 μM。它与活性位 Fe2+具有独特的单齿结合相互作用,并诱导形成一个 “Arg367-out” 口袋。 | |||
T39040 |
HIF-PHD-IN-1
|
||
HIF-PHD-IN-1 is a pharmacological compound that acts as an orally active inhibitor of the hypoxia-inducible factor prolyl hydroxylase domain (HIF-PHD), displaying an IC50 of 54 nM for hHIF-PHD2. Its potential as a therapeutic agent for renal anemia is highly promising. | |||
T79797 |
PHD-IN-1
|
HIF/HIF Prolyl-Hydroxylase | Chromatin/Epigenetic; Metabolism |
PHD-IN-1(compound 80)作为PHD2的抑制剂,显示出 IC50 ≤5 nM 的高效活性。在Caco2-HIFla-HiBiT-clone-1和Hep3B细胞系中进行的EPO Elisa实验中,其EC50值均为2.5 μM。 | |||
T75098 |
HIF-PHD-IN-3
|
Reactive Oxygen Species | Immunology/Inflammation; Metabolism; NF-κB |
HIF-PHD-IN-3 是一种有效的 hiPSC-CM 心脏保护支架,对 HIF-PHD 有潜在的抑制作用,可调节血红素加氧酶-1,可用于研究贫血。 | |||
T1823 |
IOX2
IOX 2,JICL38 |
HIF/HIF Prolyl-Hydroxylase | Chromatin/Epigenetic; Metabolism |
IOX2 (IOX 2) 是特异性的脯氨酰羟化酶-2 抑制剂,IC50=22 nM。 | |||
T61458 |
HIF-PHD-IN-2
|
||
HIF-PHD-IN-2 (compound 25) is a highly effective PHD inhibitor, displaying IC50 values below 100 nM for PHD1, PHD2, and PHD3 [1]. | |||
T12547 | Prolyl Hydroxylase inhibitor 1 | Others | Others |
Prolyl Hydroxylase inhibitor 1 is an orally active inhibitor of hypoxia inducible factor (HIF)-prolyl hydroxylase (PHD) (IC50 of 62.23 nM). | |||
T79798 |
PHD-IN-2
|
HIF/HIF Prolyl-Hydroxylase | Chromatin/Epigenetic; Metabolism |
PHD-IN-2(Compound 91)是一种高效的PHD拮抗剂,具有IC50值小于5 nM,能在HEP3B细胞中诱导促红细胞生成素的合成,EC50值小于2.5 μM。此化合物主要用于心血管、代谢、血液、肺部、肾脏、肝脏疾病、伤口愈合以及癌症等研究领域。 | |||
T78142 |
DC-BPi-11 hydrochloride
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
DC-BPi-11 hydrochloride是一种作用于溴域PHD转录因子(BPTF)的抑制剂,具有698 nM的IC50值。它对白血病细胞的增殖表现出显著的抑制效果。 | |||
T61727 |
HDAC6/8/BRPF1-IN-1
|
||
HDAC6/8/BRPF1-IN-1 is a dual inhibitor that targets HDAC6, HDAC8, and the bromodomain and PHD finger containing protein 1 (BRPF1). It exhibits inhibitory activity against HDAC1, HDAC6, and HDAC8 with IC50 values of 797 nM, 344 nM, and 908 nM, respectively. In addition, it inhibits BRPF1 with a Kd value of 175.2 nM. This compound is utilized in cancer research [1]. | |||
T12271 |
NV03
|
Others | Others |
NV03 是一种有效,选择性的UHRF1与H3K9me3相互作用的小分子拮抗剂,Kd 值为 2.4 μM。NV03 具有抗癌活性。 |